View all releases by:

    ZeptoMetrix™ Corporation (ZMC) Releases FDA Class 1 Exempt, IVD and CE Labeled NATtrol™ RP Multimarker Controls

    ZeptoMetrix™ Corporation (ZMC) Releases FDA Class 1 Exempt, IVD and CE Labeled NATtrol™ RP Multimarker ControlsJuly 25, 2014ZeptoMetrix™ Corporation (ZMC), launches a new FDA Class 1 exempt, in vitro diagnostic, CE marked, unassayed external run control intended for use with multiplexed, respiratory molecular assays. The NATtrol™ RP Multimarker Controls - MDZ001 has been specifically designed for routine and repetitive laboratory use to monitor daily test variation, lot-to-lot test kit performance, individual operator variation and may also provide assistance in identifying increases in random or systematic error(s).

    ZeptoMetrix Corporation (ZMC) in Collaboration with CytoSignet, Inc. to Offer Proactive, Patented* and Extensive Bed Bug Detection Products

    November 04, 2013ZeptoMetrix Corporation (ZMC), a fully integrated biotechnology company specializing in sensitive diagnostic test development, and CytoSignet, Inc., a leader in the development, commercialization and licensing of Intellectual Property for biochemical detection, have established an exclusive partnership to address today's worldwide Bed Bug infestation with the development of a broad family of issued patents and products to identify infestation by these global parasites.